Notes
National Health Service
Reference
NICE. NICE recommends combined drug therapy proven to extend life for skin cancer. Media Release : 29 Apr 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Trametinib + dabrafenib recommended for melanoma. PharmacoEcon Outcomes News 752, 38 (2016). https://doi.org/10.1007/s40274-016-3032-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3032-2